Late Breaking Abstract - Biomarkers for iron metabolism among patients hospitalized with community-acquired pneumonia caused by SARS-CoV-2, bacteria, and influenza
M. Hegelund (Hillerød, Denmark), A. Glenthøj (Copenhagen , Denmark), C. Ryrsø (Hillerød, Denmark), C. Ritz (Frederiksberg, Denmark), A. Dungu (Hillerød, Denmark), A. Sejdic (Hillerød, Denmark), K. List (Copenhagen, Denmark), R. Krogh-Madsen (Copenhagen, Denmark), B. Lindegaard (Copenhagen, Denmark), J. Kurtzhals (Copenhagen, Denmark), D. Faurholt-Jepsen (Copenhagen, Denmark)
Source: Virtual Congress 2021 – Diagnosis and management of COVID-19
Session: Diagnosis and management of COVID-19
Session type: E-poster
Number: 458
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Hegelund (Hillerød, Denmark), A. Glenthøj (Copenhagen , Denmark), C. Ryrsø (Hillerød, Denmark), C. Ritz (Frederiksberg, Denmark), A. Dungu (Hillerød, Denmark), A. Sejdic (Hillerød, Denmark), K. List (Copenhagen, Denmark), R. Krogh-Madsen (Copenhagen, Denmark), B. Lindegaard (Copenhagen, Denmark), J. Kurtzhals (Copenhagen, Denmark), D. Faurholt-Jepsen (Copenhagen, Denmark). Late Breaking Abstract - Biomarkers for iron metabolism among patients hospitalized with community-acquired pneumonia caused by SARS-CoV-2, bacteria, and influenza. 458
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Prevalence of atypical bacterial pathogens in hospitalized patients with community-acquired pneumonia Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013
Predictors of treatment failure in patients with bacteremic pneumococcal community-acquired pneumonia Source: Annual Congress 2013 –Pneumonia and sepsis Year: 2013
Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015
Effectiveness of immune stimulatory therapy in patient with severe community-acquired pneumonia (CAP) Source: International Congress 2014 – Different interesting issues in respiratory infections: 1 Year: 2014
Multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia Source: Annual Congress 2013 –Recent developments in pneumonia Year: 2013
Clinical and laboratory predictors of survival in patients with severe community-acquired pneumonia (CAP) Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014
PICTURE: Clinical pattern and pneumococcal infections in patients with community-acquired pneumonia (CAP) admitted to emergency department Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014
Modern etiology of severe community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016
Late Breaking Abstract - Aggravated pathology in MRSA pneumonia secondary to Influenza A virus infection diverged from decreased expression of IL-1ß Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 1 Year: 2020
Role of viruses, alone and in association with bacteria, in adults hospitalized with community-acquired pneumonia (CAP) Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia Year: 2011
Relationship between bacterial sensivity pattern and hospital antibiotic consumption,in patients with community acquired pneumonia Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014
Does previous warfarin treatment effect complications and outcome in hospitalised patients with community-acquired pneumonia? Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014
Respiratory pathogens, immunodeficiency or systemic response – What comes first in the etiology of severe community-acquired pneumonia (sCAP) Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013
How deadly is seasonal influenza-associated pneumonia? The German Competence Network for Community-Acquired Pneumonia Source: Eur Respir J 2011; 37: 1151-1157 Year: 2011
Shortening duration of antibiotic therapy according to clinical stability in patients with community-acquired pneumonia (CAP) Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014
The outcome of community-acquired pneumonia in patients with COPD, asthma and ILD - a case-control study Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014
Relation between bacteremia and septic shock in patients with pneumococcal community-acquired pneumonia Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013
Community adquired legionella pneumophila pneumonia in elderly patients Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014
Evolution of antimicrobial resistance trends in the last five years in patients with bacteremic Pneumococcal community-acquired pneumonia (CAP-SP) Source: Eur Respir J 2005; 26: Suppl. 49, 639s Year: 2005
Respiratory viral infections in community-acquired pneumonia and exacerbation of COPD: One year survey at a Japanese university hospital Source: International Congress 2014 – Different interesting issues in respiratory infections: 1 Year: 2014